by Cardio Diagnostics Inc | Jan 22, 2021 | Science
A Next-Generation Artificial Intelligence-Based Integrated Genetic-Epigenetic Prediction of 5-Year Risk for Coronary Heart Disease Author(s): Meesha Dogan, Cardio Diagnostics, Coralville IA; Ron Simons, Steve Beach, University of Georgia, Athens GA; Amaury Lendasse,...
by Cardio Diagnostics Inc | Jan 21, 2021 | Science
An Integrated Genetic-Epigenetic Tool for Predicting Atherothrombotic Brain Infarction Author(s): Meesha Dogan and Rob Philibert, Cardio Diagnostics, Coralville IA. Presented: American Heart Association Scientific Sessions 2018 Atherothrombotic Brain Infarction (ABI)...
by Cardio Diagnostics Inc | Nov 12, 2019 | Science
Precision Cardiovascular Medicine: A Rapid and Highly Sensitive Artificial Intelligence-Based Integrated Genetic-Epigenetic DNA Test for 3-Year Risk for Incident Coronary Heart Disease. Author(s): Meesha Dogan, Cardio Diagnostics, Coralville IA; Stacey Knight,...
by Cardio Diagnostics Inc | Sep 29, 2019 | News
Cardio Diagnostics received $225K in National Institutes of Health (NIH) funding to further develop our integrated genetic-epigenetic coronary heart disease risk screening technology.
by Cardio Diagnostics Inc | Sep 16, 2019 | Blog
It’s health care tailored to you. Until now, most medical treatments have been designed for the “average patient.” As a result of this “one-size-fits-all” approach, treatments can be successful for some patients but not for others. Precision Medicine, on the...
